Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias

Författare

Summary, in English

Appearance of dyskinesia is a common problem of long-term Levodopa (L-DOPA) treatment in Parkinson's disease (PD) patients and represents a major limitation for the pharmacological management of the motor symptoms in the advanced stages of disease. An increasing body of evidence points to dopamine released as a false neurotransmitter from the striatal serotonin terminals as the main pre-synaptic determinant of L-DOPA-induced dyskinesia. Here we review the animal experimental and human clinical data in support of this view, which point to the serotonin system as a promising target for anti-dyskinetic therapy in PD patients under L-DOPA medication.

Publiceringsår

2008

Språk

Engelska

Sidor

465-478

Publikation/Tidskrift/Serie

Progress in Brain Research

Volym

172

Dokumenttyp

Artikel i tidskrift

Förlag

Elsevier

Ämne

  • Neurosciences

Nyckelord

  • Animals
  • Clinical Trials as Topic
  • Dopamine
  • Dyskinesia, Drug-Induced
  • Humans
  • Levodopa
  • Parkinson Disease
  • Parkinsonian Disorders
  • Presynaptic Terminals
  • Protein Isoforms
  • Receptors, Dopamine
  • Receptors, Serotonin
  • Serotonin
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review

Status

Published

Forskningsgrupp

  • Neurobiology
  • Brain Repair and Imaging in Neural Systems (BRAINS)

ISBN/ISSN/Övrigt

  • ISSN: 1875-7855